Materiovigilance & Medical Device Safety: A France vs. India Benchmark (And What It Means for Your CMMS)

Two countries. Two regulatory systems. One shared problem.

Medical device-related adverse events are underreported in almost every healthcare market in the world. But the reasons why, and what good practice looks like, differ significantly depending on where you operate.

At Arcmedix, we work with healthcare facilities in both France and India. These are not comparable markets. The regulatory infrastructure is different. The accreditation pressure is different. The resources available to biomedical and maintenance teams are different.

What is the same: in both countries, traceability failures are the root cause of most reporting breakdowns.

Here is how the two systems compare, and what practical steps healthcare facilities can take in each context.

The Regulatory Benchmark: France vs. India

Reading this table alone tells you something important. France has a more codified, more enforced system with tighter timelines. India has a rapidly maturing system where the regulatory direction of travel is clear but implementation in individual facilities is still inconsistent.

Both contexts reward the same thing: structured internal systems that make adverse event reporting fast, traceable, and auditable.

France: A Mature System Under EU MDR Pressure

France's matériovigilance system operates across three levels: the ANSM at the national level, regional coordinators (CRMRV), and local correspondents (CLMV) embedded in public and private health establishments. All parties are required to report incidents or risks of serious incidents to the ANSM.

Manufacturers and distributors of medical devices must formally declare their matériovigilance correspondent to the ANSM. For health establishments, the CLMV is the internal linchpin: they receive reports from nursing staff, technicians, and biomedical engineers, triage severity, and escalate serious incidents within 48 hours.

The ANSM classifies incidents into four types, ranging from minor incidents (closed on receipt and tracked statistically) to serious incidents requiring immediate evaluation, external expert consultation, and a manufacturer investigation report submitted within 60 days.

What is accelerating urgency in France is the EU MDR 2017/745 integration. A new ANSM management guide for matériovigilance reports and safety notices in healthcare establishments was published in March 2025. Separately, a new decree on the reprocessing of single-use medical devices introduced a two-year pilot programme as of September 2025. Both developments add layers of traceability obligation that facilities need to be operationally ready for.

The gap in French facilities: The legal obligation is clear. The tooling to meet it in practice is not always there. CLMVs often manage their caseload through email threads and paper archives. When an ANSM inspection or HAS accreditation review arrives, rebuilding the incident trail retroactively is time-consuming and error-prone.

Practical benchmark for French facilities:

A well-run French healthcare establishment should be able to, at any moment:

1. Identify the exact device involved in a reported incident within 5 minutes (UDI, serial number, location)

2. Pull a complete service and calibration history for that device

3. Show the internal escalation chain from initial report to ANSM notification

4. Demonstrate that the device was quarantined or cleared before returning to clinical use

5. Export a structured report compatible with the Vigimater tracking reference

India: A System Accelerating Fast

India's equivalent is the Materiovigilance Programme of India (MvPI), operated by the Indian Pharmacopoeia Commission under the Ministry of Health.

MvPI encourages reporting of all types of adverse events related to medical devices, whether known or unknown, serious or non-serious. Reports are reviewed at the National Coordination Centre (NCC-MvPI), entered into the safety database, and assessed by experts to identify new signals.

All medical practitioners, biomedical and clinical engineers, hospital technology managers, pharmacists, nurses, and technicians, whether public or private sector, can submit reports directly to NCC-MvPI via the IPC portal, email, or a dedicated toll-free line.

The regulatory pressure is increasing. In May 2024, the CDSCO issued a formal circular requiring all licensed medical device manufacturers to use the MvPI portal for self-reporting adverse events, with the objective of reducing the likelihood of recurrence of adverse events and improving patient and healthcare professional safety.

Then in November 2024, the DCGI introduced revisions to the MvPI programme, including a revamped adverse event reporting form with greater product detail requirements, risk classification, and importer and manufacturer licence numbers. The updated process also ensures patient and reporter confidentiality to foster a culture of open reporting.

India also published a new risk-based surveillance strategy for imported medical devices in September 2024, varying scrutiny intensity according to public health impact, with high-priority products like diagnostic kits facing stricter controls.

Facilities that are not building internal adverse event management systems now will face a compliance gap that will only widen.

The gap in Indian facilities: NABH-accredited private hospitals are increasingly expected to demonstrate structured biomedical equipment management as part of their ME standard compliance. In practice, most biomedical teams are managing 500 to 1,500+ devices with two to four engineers, often without a centralized digital asset register. When an adverse event occurs, identifying the device, its maintenance history, and its calibration status is a manual process that can take days.

Practical benchmark for Indian facilities:

A NABH-ready Indian healthcare establishment should be able to, at any moment:

1. Match any reported device incident to a unique asset record with manufacturer, model, and serial number

2. Show the last five preventive maintenance interventions on that device

3. Demonstrate that the device was removed from service and a corrective work order was opened

4. Provide a written incident report exportable for NABH documentation or MvPI submission

5. Show a history of PM compliance across the full Class C/D device inventory

   
   

What Both Systems Have in Common

Strip away the regulatory architecture, and both France and India are measuring the same thing: can you prove that a device was properly managed throughout its lifecycle, and can you trace what happened when something went wrong?

The five checkpoints are identical in both contexts:

1. Device identification: a unique, searchable asset record with full manufacturer data, UDI or registration number, location, and commissioning date.

2. Maintenance and calibration history: a complete, timestamped log of every intervention, by whom, with what parts, and with what outcome noted.

3. Incident linkage: the ability to connect a reported event directly to a specific asset and see whether similar issues appeared previously.

4. Escalation trail: an auditable record of who was notified internally, when, what decision was made, and whether the relevant authority (ANSM / MvPI) was informed.

5. Return-to-service verification: documented confirmation that a device was retested and cleared by an authorized person before going back into clinical use.

In most facilities we visit, steps 3 and 4 are the weakest. Not because the people are negligent. Because the data lives in different places, and connecting it under time pressure is hard without a system.

How Arcmedix Supports Both Regulatory Contexts

Arcmedix was built around the assumption that maintenance data has regulatory consequences.

Centralized asset register with full device profiles

Every device carries its complete identity: category, manufacturer, model, serial number, location, commissioning date, warranty status, and applicable regulatory references.

One source of truth, accessible in seconds, from any device.

Work order history linked to each asset

Every intervention, preventive or corrective, is logged against the device. Technician, date, parts used, observations noted. A pattern of repeated anomalies is visible before it becomes a patient safety event.

Incident flagging and quarantine workflow

When a device is implicated in an adverse event, it can be flagged directly in the platform, its status changed to quarantine or out of service, and a corrective work order opened immediately. The device cannot be reassigned or cleared until the flag is resolved with a documented outcome.

This creates the audit trail that both ANSM inspectors and NABH assessors look for.

Structured documentation export

Arcmedix generates intervention reports and maintenance summaries that can be exported for ANSM declarations, NABH documentation packages, MvPI submissions, or JCI audits. The data is structured, attributed, and dated. No reconstruction required.

Multi-site visibility

For hospital groups managing several facilities, a matériovigilance correspondent or biomedical director can monitor flagged devices and open incidents across the entire network in one view.

Learn more about Arcmedix for Healthcare Facilities

Three Tips Specific to France

1. Plug your CLMV directly into your CMMS. Most CLMVs receive reports but have no access to maintenance records. Give them read access to the asset and work order modules. When an incident arrives, the device profile and service history should be in front of them within two minutes, not two days.

2. Build the 48-hour clock into your workflow. Serious incidents in France require ANSM notification within 48 hours. That clock starts when the incident is first reported internally. A CMMS that timestamps every report, every status change, and every escalation step gives you proof that you met the deadline, whether or not an inspection ever comes.

3. Use PM compliance data as a defence. The ANSM considers whether a device was properly maintained when assessing accountability after an incident. A CMMS that tracks preventive maintenance completion rates by device category gives you evidence of systematic diligence. "We had a structured PM programme with 94% completion on Class IIb devices" is a very different conversation from "we tried our best."

Link to ANSM reporting form

Link to ANSM adverse event list

Three Tips Specific to India

1. Use NABH ME standards as your CMMS configuration guide. Even if NABH accreditation is not your immediate goal, the ME standards define exactly what a compliant biomedical equipment management system looks like. Configure your Arcmedix asset categories, PM schedules, and work order workflows to the ME standard from day one. When accreditation becomes a priority, you are already most of the way there.

2. Start with Class C and Class D devices. You may not be able to digitize 1,200 devices in week one. Prioritise your highest-risk equipment: critical care, life support, surgical, and anaesthesia. These are the devices where an adverse event carries the highest patient safety consequence and the highest regulatory scrutiny under MvPI.

3. Build your MvPI submission capability before you need it. The November 2024 MvPI revisions added more structured data requirements to adverse event reports: risk classification, licence numbers, detailed event descriptions, corrective measure proposals. A CMMS that already captures all of this at the asset and incident level makes submission a copy-paste exercise, not a crisis response.

Link to MvPI website

The Regulatory Direction

France and India are moving in the same direction, at different speeds.

In France, EU MDR integration is tightening post-market surveillance obligations year by year. UDI tracking, EUDAMED integration, and new single-use device reprocessing rules all increase the traceability burden on facilities. HAS accreditation reviews are becoming more data-intensive.

In India, the CDSCO's 2024 MvPI circular, the revised reporting form with mandatory risk classification fields, and the broader push toward NABH accreditation in private healthcare are all converging toward a world where "we have a notebook" is no longer an acceptable answer to a regulatory body.

The facilities investing in structured maintenance management now are building the compliance infrastructure that will be mandatory within five years. And they are doing it while they still have the time and space to do it calmly.

One Question Worth Asking Today

When was the last adverse event involving a medical device reported in your facility?

Where is that report now?

Can you pull the full service history of the device involved in under five minutes?

If the answer is no in France or in India, the gap between your current setup and your regulatory obligation is probably larger than it looks. And it is narrowing from the outside.

Ready to Build a Traceable, Audit-Ready Maintenance System?

Arcmedix gives healthcare facilities a CMMS built for compliance, in France, in India, and across every market where equipment failure cannot be left to chance. Full asset register, work order histories, incident flagging, PM tracking, and exportable documentation, in one platform, no IT infrastructure required.

Book a 20-minute demo and see what full traceability looks like for your facility.